I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Correction to: Phase I dose escalation study of BI 836826 (..:
Kroschinsky, Frank
;
Middeke, Jan Moritz
;
Janz, Martin
...
Investigational New Drugs. 39 (2020) 1 - p. 283-284 , 2020
Link:
https://doi.org/10.1007/s10637-020-00949-8
RT Journal T1
Correction to: Phase I dose escalation study of BI 836826 (CD37 antibody) in patients with relapsed or refractory B-cell non-Hodgkin lymphoma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1007_s10637-020-00949-8&Exemplar=1&LAN=DE A1 Kroschinsky, Frank A1 Middeke, Jan Moritz A1 Janz, Martin A1 Lenz, Georg A1 Witzens-Harig, Mathias A1 Bouabdallah, Reda A1 La Rosée, Paul A1 Viardot, Andreas A1 Salles, Gilles A1 Kim, Seok Jin A1 Kim, Tae Min A1 Ottmann, Oliver A1 Chromik, Joerg A1 Quinson, Anne-Marie A1 von Wangenheim, Ute A1 Burkard, Ute A1 Berk, Andreas A1 Schmitz, Norbert PB Springer Science and Business Media LLC YR 2020 SN 0167-6997 SN 1573-0646 JF Investigational New Drugs VO 39 IS 1 SP 283 OP 284 LK http://dx.doi.org/https://doi.org/10.1007/s10637-020-00949-8 DO https://doi.org/10.1007/s10637-020-00949-8 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)